Back to Superinvestors
SUPERINVESTOR HOLDERS
BMRN
Biomarin Pharmaceutical Inc
Healthcare · Biotechnology
- Holders
- 6
- Total value
- $2,422,128,695
- Total shares
- 42,392,858
- Cross-link
- Financials →
| Investor | Shares | Value | % of Portfolio | Activity | As of |
|---|---|---|---|---|---|
|
Dodge & Cox
Dodge & Cox
|
14,844,930 | $849,426,895 | 0.45% | ADD +283,171 | 30 Jun 2026 |
|
PRIMECAP Management
PRIMECAP Management Co
|
14,190,183 | $811,962,329 | 0.48% | REDUCE -3,822 | 30 Jun 2026 |
|
Andreas Halvorsen
Viking Global Investors
|
7,616,563 | $435,819,735 | 1.24% | ADD +554,486 | 30 Jun 2026 |
|
Cliff Asness
AQR Capital Management
|
5,699,541 | $322,537,038 | 0.11% | REDUCE -1,977,000 | 30 Jun 2026 |
|
Joel Greenblatt
Gotham Asset Management
|
28,641 | $1,638,838 | 0.00% | REDUCE -145,450 | 30 Jun 2026 |
|
Mario Gabelli
GAMCO Investors
|
13,000 | $743,860 | 0.01% | REDUCE -150 | 30 Jun 2026 |